Physician profile

Thomas M Snodell

Internal Medicine · Roeland Park, KS

NPI 1952307431

$2,678.08

in general payments reported to CMS, 2019-2025

31 companies · $378 in 2025

The $378 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

See the full distribution for Internal Medicine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,699.39

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Lilly USA, LLC $452.52 2022-2025 Jardiance, Emgality, Zepbound
Abbott Laboratories $292.75 2022-2025 Freestyle Libre 3
Novo Nordisk INC $289.28 2022-2025 Ozempic, Rybelsus, Wegovy
Pfizer INC. $245.59 2022-2025
Abbvie INC. $166.39 2022-2025 Ubrelvy, Synthroid
Amarin Pharma, INC. $133.58 2019
Daiichi Sankyo INC. $118.94 2021-2023 Injectafer
Teva Pharmaceuticals USA, INC. $109.24 2022-2025 Ajovy, Austedo Xr, Austedo
Astrazeneca Pharmaceuticals LP $102.02 2022-2025 Airsupra, Farxiga, Breztri
Astellas Pharma US INC $94.88 2023-2025 Veozah, Myrbetriq
Bayer Healthcare Pharmaceuticals INC. $67.87 2023
Biohaven Pharmaceutical Holding Company LTD. $55.87 2022
Amgen INC. $48.06 2022-2025 Otezla, Repatha
Glaxosmithkline, LLC. $43.87 2023-2025 Shingrix, Arexvy
Exact Sciences Corporation $43.55 2023-2024 Cologuard Collection Kit
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Lundbeck LLC $42.99 2023-2024 Vyepti
Novartis Pharmaceuticals Corporation $42.11 2022-2023
Boston Scientific Corporation $41.06 2024 Wavewriter Alpha Prime 16
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $40.77 2022-2024 Xifaxan, Trulance
Boehringer Ingelheim Pharmaceuticals, INC. $35.36 2022-2024 Jardiance
Corium, LLC $34.42 2022-2023 Azstarys
Sumitomo Pharma America, INC. $28.56 2023 Gemtesa
Dexcom, INC. $19.76 2024 Dexcom G6 Transmitter
E.R. Squibb & Sons, L.L.C. $19.08 2023 Eliquis
Sanofi Pasteur INC. $18.51 2023
Impel Pharmaceuticals INC. $18.47 2023 Trudhesa
Hologic Sales and Service, LLC $18.24 2024 Thinprep 2000 Processor, Aptima
Merck Sharp & Dohme LLC $16.23 2024 Gardasil, Gardasil 9, Capvaxive
Nevro Corp. $14.83 2020
Idorsia Pharmaceuticals US INC $14.42 2022
Endogastric Solutions, INC $8.86 2023 Esophyx

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas M Snodell

$2,678.08

in general payments reported 2019-2025

Years
2019-2025
Top company
Lilly USA, LLC
Context
The $378 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/931041/thomas-m-snodell

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.